These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8211968)

  • 1. Chronic treatment with anti-endothelin antibodies fails to modify the development of hypertension in stroke-prone spontaneously hypertensive rats and DOCA-salt hypertensive rats.
    Yasujima M; Kanazawa M; Yoshida K; Kohzuki M; Watanabe H; Hiwatari M; Sato T; Abe K; Hirata Y; Yoshinaga K
    Tohoku J Exp Med; 1993 Jan; 169(1):43-50. PubMed ID: 8211968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
    Schiffrin EL; Lariviere R; Li JS; Sventek P; Touyz RM
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats.
    Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
    Hypertension; 1995 Apr; 25(4 Pt 2):769-73. PubMed ID: 7721430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endothelin-3 on blood pressure in conscious spontaneously hypertensive [SHR] and DOCA-salt hypertensive rats.
    Januszewicz A; Loń S; Lapiński M; Styś A
    J Physiol Pharmacol; 1994 Mar; 45(1):105-19. PubMed ID: 8043901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
    Matsumura Y; Fujita K; Miyazaki Y; Takaoka M; Morimoto S
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S456-8. PubMed ID: 8587444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effects of BQ-123, a selective endothelin ETA receptor antagonist, in spontaneously hypertensive rats treated with DOCA-salt.
    Okada M; Fukuroda T; Shimamoto K; Takahashi R; Ikemoto F; Yano M; Nishikibe M
    Eur J Pharmacol; 1994 Jul; 259(3):339-42. PubMed ID: 7982465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
    Larivière R; Sventek P; Thibault G; Schiffrin EL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats.
    Suzuki N; Miyauchi T; Tomobe Y; Matsumoto H; Goto K; Masaki T; Fujino M
    Biochem Biophys Res Commun; 1990 Mar; 167(3):941-7. PubMed ID: 2182029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Ueda M; Tatsumi Y; Yoshikawa J
    Metabolism; 1997 Sep; 46(9):1032-8. PubMed ID: 9284892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
    Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
    Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
    J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
    Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
    Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic effects of anti-endothelin-1 antibody on blood pressure in spontaneously hypertensive rats.
    Kinoshita O; Kawano Y; Yoshimi H; Ashida T; Yoshida K; Akabane S; Kuramochi M; Omae T
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S511-3. PubMed ID: 1725428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats.
    Vemulapalli S; Watkins RW; Brown A; Cook J; Bernardino V; Chiu PJ
    Life Sci; 1993; 53(10):783-93. PubMed ID: 8355566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K; Matsumura Y; Kita S; Miyazaki Y; Hisaki K; Takaoka M; Morimoto S
    Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.